These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37504965)

  • 21. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants.
    Mojarab S; Shahbazzadeh D; Moghbeli M; Eshraghi Y; Bagheri KP; Rahimi R; Savoji MA; Mahdavi M
    Microb Pathog; 2020 Mar; 140():103932. PubMed ID: 31857237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
    Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
    Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of the inactivated SARS-CoV-2 vaccine potency through formulation in alum/naloxone adjuvant; Robust T cell and anti-RBD IgG responses.
    Haghighi M; Khorasani A; Karimi P; Mahdavi M
    Iran J Basic Med Sci; 2022 May; 25(5):554-561. PubMed ID: 35911642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT
    Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly-γ-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine.
    Nguyen QT; Kwak C; Lee WS; Kim J; Jeong J; Sung MH; Yang J; Poo H
    Front Immunol; 2019; 10():1604. PubMed ID: 31354739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Sabbaghi A; Zargar M; Zolfaghari MR; Motamedi-Sedeh F; Ghaemi A
    Arch Virol; 2021 Feb; 166(2):545-557. PubMed ID: 33409549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii.
    Khosroshahi KH; Ghaffarifar F; Sharifi Z; D'Souza S; Dalimi A; Hassan ZM; Khoshzaban F
    Parasitol Res; 2012 Jul; 111(1):403-11. PubMed ID: 22350714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamins as influenza vaccine adjuvant components.
    Quintilio W; de Freitas FA; Rodriguez D; Kubrusly FS; Yourtov D; Miyaki C; de Cerqueira Leite LC; Raw I
    Arch Virol; 2016 Oct; 161(10):2787-95. PubMed ID: 27449155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice.
    Mortazavi SS; Haghighat S; Mahdavi M
    Microb Pathog; 2020 Mar; 140():103945. PubMed ID: 31874228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses.
    Kalanaky S; Fakharzadeh S; Karimi P; Hafizi M; Jamaati H; Hassanzadeh SM; Khorasani A; Mahdavi M; Nazaran MH
    Viral Immunol; 2023; 36(6):409-423. PubMed ID: 37506342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Immunogenicity of Alum and MF59-Like Adjuvant Inactivated SARS-CoV-2 Vaccines Against SARS-CoV-2 Variants in Elderly Mice.
    Bai S; Kang Y; Chen W; Xie H; Zhang L; Lv M; Wang J; Wu J; Zhao W
    Viral Immunol; 2023 Oct; 36(8):526-533. PubMed ID: 37625037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
    Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
    J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine.
    Sabbaghi A; Malek M; Abdolahi S; Miri SM; Alizadeh L; Samadi M; Mohebbi SR; Ghaemi A
    Virol J; 2021 Oct; 18(1):201. PubMed ID: 34627297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes.
    Rosenkrands I; Vingsbo-Lundberg C; Bundgaard TJ; Lindenstrøm T; Enouf V; van der Werf S; Andersen P; Agger EM
    Vaccine; 2011 Aug; 29(37):6283-91. PubMed ID: 21722683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Responses to Adjuvanted H7N9 Split Antigen in Aged Mice.
    Zhao W; Zhang P; Bai S; Lv M; Wang J; Chen W; Wu J
    Viral Immunol; 2021 Mar; 34(2):112-116. PubMed ID: 33577421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.